hrcak mascot   Srce   HID

Kratko priopćenje

Effect of Erythropoietin in a Patient with Severe Congestive Heart Failure – A Case Report

Tea Carić
Ozren Đerek
Drago Carić

Puni tekst: engleski, pdf (52 KB) str. 641-643 preuzimanja: 329* citiraj
APA 6th Edition
Carić, T., Đerek, O. i Carić, D. (2008). Effect of Erythropoietin in a Patient with Severe Congestive Heart Failure – A Case Report. Collegium antropologicum, 32 (2), 641-643. Preuzeto s https://hrcak.srce.hr/27191
MLA 8th Edition
Carić, Tea, et al. "Effect of Erythropoietin in a Patient with Severe Congestive Heart Failure – A Case Report." Collegium antropologicum, vol. 32, br. 2, 2008, str. 641-643. https://hrcak.srce.hr/27191. Citirano 21.11.2019.
Chicago 17th Edition
Carić, Tea, Ozren Đerek i Drago Carić. "Effect of Erythropoietin in a Patient with Severe Congestive Heart Failure – A Case Report." Collegium antropologicum 32, br. 2 (2008): 641-643. https://hrcak.srce.hr/27191
Harvard
Carić, T., Đerek, O., i Carić, D. (2008). 'Effect of Erythropoietin in a Patient with Severe Congestive Heart Failure – A Case Report', Collegium antropologicum, 32(2), str. 641-643. Preuzeto s: https://hrcak.srce.hr/27191 (Datum pristupa: 21.11.2019.)
Vancouver
Carić T, Đerek O, Carić D. Effect of Erythropoietin in a Patient with Severe Congestive Heart Failure – A Case Report. Collegium antropologicum [Internet]. 2008 [pristupljeno 21.11.2019.];32(2):641-643. Dostupno na: https://hrcak.srce.hr/27191
IEEE
T. Carić, O. Đerek i D. Carić, "Effect of Erythropoietin in a Patient with Severe Congestive Heart Failure – A Case Report", Collegium antropologicum, vol.32, br. 2, str. 641-643, 2008. [Online]. Dostupno na: https://hrcak.srce.hr/27191. [Citirano: 21.11.2019.]

Sažetak
Erythropoietin (EPO), traditionally known as a hematopoietic hormone, has recently been shown to have effects beyond
hematopoiesis such as prevention of neuronal and cardiac apoptosis secondary to ischemia and induction of neoangiogenesis4,5,12,13.
Patients with congestive heart failure (CHF) suffer considerable morbidity and mortality despite advances
in therapy. Anemia, CHF, and chronic kidney insuficiency often coexist and interact to cause or worsen each other
in the so-called cardio-renal anemia syndrome3. Treatment with EPO has shown promise in such patients. The paper reviews
a case of a successful recovery of cardiac function in a patient with a severe CHF during the treatment with EPO.

Ključne riječi
cardio-renal anemia; heart failure; erythropoietin; apoptosis

Hrčak ID: 27191

URI
https://hrcak.srce.hr/27191

Posjeta: 494 *